Procaccianti Hotel REIT (NASDAQ: PRXA) director receives 250 restricted shares
Rhea-AI Filing Summary
Procaccianti Hotel REIT, Inc. director equity grant reported
Director Thomas R. Engel reported receiving 250 restricted shares of Procaccianti Hotel REIT, Inc. Class K common stock on 01/19/2026. This was an acquisition at a stated price of $0 per share under the company’s long-term incentive plan, bringing his directly held Class K common stock to 2,250 shares following the transaction.
The restricted shares vest in four equal annual installments of 25% each, starting on the first anniversary of the grant date. The award will become fully vested earlier if Mr. Engel’s service as a director ends because of death or disability, or if there is a change in control of the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class K Common Stock | 250 | $0.00 | $0.00 |
Footnotes (1)
- F1. Mr. Engel received a grant of 250 restricted shares of Class K common stock under the long-term incentive plan. The shares will vest in equal amounts annually over a four-year period on and following the first anniversary of the date of grant in increments of 25% per annum; provided, however, that the shares will become fully vested on the earlier to occur of (1) the termination of Mr. Engel's service as a director due to his death or disability, or (2) a change in control of the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did PRXA disclose for director Thomas R. Engel?
The company disclosed that director Thomas R. Engel acquired 250 restricted shares of Class K common stock on 01/19/2026 under its long-term incentive plan.
Is the PRXA director’s ownership reported as direct or indirect on this Form 4?
The filing states that Thomas R. Engel’s 2,250 Class K common shares after the transaction are held with direct (D) ownership.